Basic Information | Post buying leads | Suppliers |
Name |
9,9-Dimethyl-10-dimethylaminopropyl-acridan hydrogen tartrate |
EINECS | N/A |
CAS No. | 3759-07-7 | Density | N/A |
PSA | 121.54000 | LogP | 2.35810 |
Solubility | N/A | Melting Point |
N/A |
Formula | C20H26N2•C4H4O6 | Boiling Point | 406.4°C at 760 mmHg |
Molecular Weight | 442.56 | Flash Point | 180.4°C |
Transport Information | N/A | Appearance | N/A |
Safety | Poison by ingestion, intravenous, and intraperitoneal routes. Moderately toxic by subcutaneous route. Experimental teratogenic and reproductive effects. When heated to decomposition it emits toxic fumes of NOx. | Risk Codes | N/A |
Molecular Structure | Hazard Symbols | N/A | |
Synonyms |
Dimetacrin-hydrogentartrat;9,9-DIMETHYL-10-DIMETHYLAMINOPROPYL-ACRIDAN HYDROGEN TARTRATE; |
Molecular Structure of 9,9-Dimethyl-10-dimethylaminopropyl-acridan hydrogen tartrate (CAS NO.3759-07-7):
IUPAC Name: (2R,3R)-2,3-dihydroxybutanedioic acid; 3-(9,9-dimethylacridin-10-yl)-N,N-dimethylpropan-1-amine
Empirical Formula: C24H32N2O6
Molecular Weight: 444.5207
Flash Point: 180.4 °C
Enthalpy of Vaporization: 65.81 kJ/mol
Boiling Point: 406.4 °C at 760 mmHg
Vapour Pressure: 8.19E-07 mmHg at 25°C
Synonyms of 9,9-Dimethyl-10-dimethylaminopropyl-acridan hydrogen tartrate (CAS NO.3759-07-7):
dimetacrine tartrate ; Miroistonil ; Mo-709 ; SD-709 ; Dimetacrine Bitartrate ; 5,5-Dimethyl-10-dimethylaminopropylacridan Tartrate (1:1) ; N,N,9,9-Tetramethyl-10(9H)-acridinepropanamine (R-(R*,R*))-2,3-Dihydroxybutanedioate (1:1) ; 10(9H)-Acridinepropanamine, N,N,9,9-tetramethyl-, (R-(R*,R*))-2,3-dihydroxybutanedioate (1:1) ; N,N,9,9-Tetramethyl-10(9H)-acridinepropanamine (R-(R*,R*))-2,3-Dihydroxybutanedioate (1:1) ; 5,5-Dimethyl-10-dimethylaminopropylacridan Tartrate (1:1) ; Acridan, 10-(3-(dimethylamino)propyl)-9,9-dimethyl-, tartrate (1:1) (8CI) ; 9,9-Dimethyl-10-dimethylaminopropylacridan hydrogen tartrate
1. | orl-mus TDLo:175 mg/kg (female 7-13D post):REP | OYYAA2 Oyo Yakuri. Pharmacometrics. 4 (1970),855. | ||
2. | orl-rat LD50:1671 mg/kg | ARZNAD Arzneimittel-Forschung. Drug Research. 24 (1974),1098. | ||
3. | ipr-rat LD50:203 mg/kg | OYYAA2 Oyo Yakuri. Pharmacometrics. 4 (1970),855. | ||
4. | scu-rat LD50:1214 mg/kg | OYYAA2 Oyo Yakuri. Pharmacometrics. 4 (1970),855. | ||
5. | ivn-rat LD50:38 mg/kg | WKWOAO Wiener Klinische Wochenschrift. 78 (1966),21. | ||
6. | orl-mus LD50:860 mg/kg | WKWOAO Wiener Klinische Wochenschrift. 78 (1966),21. | ||
7. | ipr-mus LD50:175 mg/kg | WKWOAO Wiener Klinische Wochenschrift. 78 (1966),21. | ||
8. | scu-mus LD50:798 mg/kg | OYYAA2 Oyo Yakuri. Pharmacometrics. 4 (1970),855. | ||
9. | ivn-mus LD50:40,900 µg/kg | OYYAA2 Oyo Yakuri. Pharmacometrics. 4 (1970),855. | ||
10. | orl-cat LD50:150 mg/kg | WKWOAO Wiener Klinische Wochenschrift. 78 (1966),21. | ||
11. | ivn-cat |
9,9-Dimethyl-10-dimethylaminopropyl-acridan hydrogen tartrate (CAS NO.3759-07-7) was reported in ARZNAD Arzneimittel-Forschung. Drug Research.
Poison by ingestion, intravenous, and intraperitoneal routes. Moderately toxic by subcutaneous route. Experimental teratogenic and reproductive effects. When heated to decomposition it emits toxic fumes of NOx.